Latest Security News

Norwood Systems has landed a paid pilot trial with a major UK telecom to showcase its OpenSpan AI orchestration and CogVoice applications, marking a key step in its international expansion.

Rokeby Resources appoints Richard Beazley as Managing Director and Tim Pallas as Chairman, signalling a strategic leadership overhaul to support the acquisition and development of the high-grade Omeo Gold Project in Victoria.

Critica Limited is progressing its Jupiter and Mt Lindsay projects with key resource updates, metallurgical breakthroughs, and strategic partnerships, targeting Scoping Study completion in Q3 2026.

Zinc of Ireland (ASX: ZMI) has finalised its acquisition of Meclex, securing two hydrometallurgical technologies aimed at disrupting zinc and lead processing with low-emission methods. Backed by a fresh A$5.5 million placement, ZMI is accelerating pilot plant development and exploration at its Kildare project.

Neurizon Therapeutics has secured a critical five-year supply agreement with Elanco Animal Health for GMP-grade monepantel, underpinning the commercialisation readiness of its lead ALS drug candidate NUZ-001.

St George Mining has raised A$60 million through a two-tranche placement led by major shareholder Hancock Prospecting to accelerate development of its high-grade Araxá rare earths and niobium project in Brazil.

Great Divide Mining Ltd (ASX: GDM) has received its first cash payment of USD 78,480.35 from gold concentrate sales at its Challenger Gold Mine, marking a key milestone in its transition from explorer to producer within three years of listing.

Turaco Gold’s pre-feasibility study for the Afema Gold Project in Côte d’Ivoire reveals a maiden 1.91 million ounce Probable Ore Reserve and robust project economics, underpinning a 10.3-year mine life producing over 2 million ounces of gold.

Victory Metals has achieved a major processing milestone at its North Stanmore Project, producing a 7.1% Total Rare Earth Oxide concentrate with 40% heavy rare earth oxides through continuous flotation at pilot scale.

Island Pharmaceuticals has won a key regulatory boost as the US FDA granted Orphan Drug Designation to Galidesivir for post-exposure prophylaxis of Marburg virus disease, enhancing its commercial and development prospects.

Harvest Technology Group has transitioned from assessing to actively executing its international defence market strategy by engaging a US national security advisory firm and appointing Dr Oleksandra Molloy as Defence Strategic Advisor for Europe.

SciDev Ltd has completed a strategic review addressing past underperformance and is refocusing on an integrated water solutions platform targeting core markets. The company confirmed FY26 guidance with revenue of $82 to $87 million and underlying EBITDA of approximately $4 million, while maintaining a sound balance sheet.